Table 2.

Summary of WHO European Region countries with identified policies or guidelines^a relating to TB, HIV, HBV and HCV infection and refugees and migrants, and the alignment of these with WHO and ECDC guidance

TB	HIV	HBV/HCV
Belgium	Azerbaijan	France
Finland	Bosnia and Herzegovina	Italy
France	Bulgaria	UK
Germany	Cyprus
Greece	Czechia
Ireland	France
Italy	Greece
The Netherlands	Israel
Norway	Kazakhstan
Russian Federation	Kyrgyzstan
Spain	Luxembourg
Sweden	Russian Federation
Switzerland	Turkmenistan
UK	Ukraine
	UK
Of all (n = 53) WHO European Region countries: 14 (26%) have any identified TB guidance/policies 8 (15%) have guidance/policies in alignment with the WHO/ECDC	Of all (n = 53) WHO European Region countries: 15 (28%) have any identified HIV guidance/policies 3 (6%) have guidance/policies in alignment with the WHO/ECDC	Of all (n = 53) WHO European Region countries: 3 (6%) have any identified HBV/HCV guidance/policies 2 (4%) have guidance/policies in alignment with the WHO/ECDC

All countries listed are identified as having some refugee/migrant-specific policies in place (either national policy/guidance documents identified, or secondary reporting of national policies through articles included in our review). Green—policies/guidance broadly in alignment with WHO/ECDC guidance, as summarized in Table 1; amber—insufficient information on policies/guidance to determine alignment, or in partial alignment only; red—policies/guidance in contradiction with WHO/ECDC (in all cases, this related to discrimination against PLWH: restriction of movement and/or confidential and voluntary testing).

^a‘Relevant’ is defined as any guidance or policy relating to the relevant infectious disease and refugees and migrants. Guidance and policy documents are included if they were identified by this review or were cited by other reviewed publications.